Phosphoinositide Signaling and Evolution
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 161
Special Issue Editor
Special Issue Information
Dear Colleagues,
Phosphoinositides are relatively non-abundant phospholipids that are present in all eukaryotic cells and they regulate almost all aspects of eukaryotic cell physiology. They serve as prominent second messengers or precursors of second messengers, membrane barcodes, cytosolic protein membrane recruiters, cell polarity tags, and ion channel co-factors amongst other functions. Due to a complex set of dedicated kinases and phosphatases that result in their interconversion, they also function as molecular ON-OFF switches regulating receptor signaling, membrane trafficking and cytoskeletal reorganization.
This Special Issue on “ Phosphoinositide Signaling and Evolution” aims to publish cutting-edge original research and review articles on phosphoinositide roles and functions in eukaryotic cells and advance our understanding of why these lipids gained such a important role in eukaryotic cell regulation during evolution. We also wellcome submissions aiming at characterizing phosphoinositide kinases/phosphatases/phospholipases roles in human diseases. We look forward to receiving your contributions.
Dr. George Leondaritis
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phosphoinositide
- signaling
- trafficking
- cytoskeleton
- kinase
- phosphatase
- phospholipase
- disease
- evolution
